Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, more recently, obesity
Where indicated, a subset of subjects were instructed to continue with their current diet but, in addition, were placed on oral l-carnitine supplement (500 mg l-carnitine tartrate daily) and rechallenged in follow-up visits at 1 month and 23 months from baseline
cerevisiae cells were selected
What has been approved The licensed indication mirrors the injectable: adults with a BMI of 30 or above, or 27 to 30 with at least one weight-related comorbidity, used alongside a reduced-calorie diet and increased physical activity (MHRA, 2026)
Other Ingredients: Purified water, vegetable glycerin, sunflower lecithin with tocopherols, natural flavors, organic acacia gum, potassium sorbate, Lipid-Protect [oleic acid, CoQ10, tocotrienols with carotenoids, cetyl myristoleate (from Kombo nut oil)(Pycanthus angolensis), astaxanthin (from Haematococcus pluvialis algae oil)]
.2308070949550.jpg)
